MedPath

Effect Of Sleep Apnea Treatment On Temporo-Mandibular Disorders

Not Applicable
Completed
Conditions
Sleep Apnea Syndromes
Pain, Face
Temporomandibular Disorder
Sleep Apnea
Pain
Sleep Apnea, Obstructive
Interventions
Other: no treatment
Combination Product: osa treatment
Registration Number
NCT04948541
Lead Sponsor
Anna Alessandri Bonetti
Brief Summary

Aims of this research are to detect if an improvement in sleep pattern in patients suffering from obstructive sleep apnea (OSA), produces a reduction in pain and dysfunction in the orofacial area by examining variation in temporo-mandibular disorder (TMD) signs and symptoms and if the prevalence of TMDs in OSA patients controlling this disease decreases to levels comparable to healthy subjects.

41 OSA patients will undergo a complete TMD examination prior to start any OSA treatment and after at least 18 months of therapy. Variations in TMD signs and symptoms will be recorded.

Detailed Description

Since a bidirectional relationship has been suggested for poor sleep and pain and considering that patients suffering from obstructive sleep apnea (OSA) have been reported to present a higher prevalence of temporo-mandibular disorder (TMD) signs and symptoms compared to healthy controls; aims of this research are to detect if an improvement in sleep pattern in patients suffering from OSA, produces a reduction in pain and dysfunction in the orofacial area by examining variation in TMD signs and symptoms and if the prevalence of TMDs in OSA patients controlling this disease decreases to levels comparable to healthy subjects.

41 OSA patients will undergo a complete TMD examination prior to start any OSA treatment and after at least 18 months of therapy. Variations in TMD signs and symptoms will be recorded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patients suffering from OSA diagnosed by polysomnography not yet undergoing treatment
Exclusion Criteria
  • patients presenting some kind of cognitive impairment, due to difficulties in undergoing TMD examination
  • patients presenting dental problems
  • patients assuming medications that would alter pain perception
  • patients not signing the informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
no treatmentno treatment-
treatmentosa treatment-
Primary Outcome Measures
NameTimeMethod
variation in TMD prevalence according to diagnostic criteria for temporo-mandibular disorderschange from baseline temporo-mandibular disorders at 18 months

prevalence described as percentage of people having the disease

Secondary Outcome Measures
NameTimeMethod
reduction of TMD signs according to diagnostic criteria for temporo-mandibular disorderchange from baseline temporo-mandibular disorder signs at 18 months

reduction described as percentage of people resolving the disease

reduction of TMD symptoms according to diagnostic criteria for temporo-mandibular disorderchange from baseline temporo-mandibular disorder symptoms at 18 months

reduction in pain described by patients through a numeric rating scale going from 0 to 10, were 0 is no pain and 10 is the worst immaginabile pain

Trial Locations

Locations (1)

Policlinico Universitario A. Gemelli IRCCS

🇮🇹

Roma, RM, Italy

© Copyright 2025. All Rights Reserved by MedPath